Evaluating the Cost-Effectiveness of Liquid Biopsy for Diagnosing Burkitt Lymphoma in Pediatric and Young Adult Populations: A Health Economic Study in Tanzania - Scorecard - MDSpire
Advertisement
Evaluating the Cost-Effectiveness of Liquid Biopsy for Diagnosing Burkitt Lymphoma in Pediatric and Young Adult Populations: A Health Economic Study in Tanzania
Clinical Scorecard: Evaluating the Cost-Effectiveness of Liquid Biopsy for Diagnosing Burkitt Lymphoma in Pediatric and Young Adult Populations: A Health Economic Study in Tanzania
At a Glance
Category
Detail
Condition
Burkitt Lymphoma
Key Mechanisms
Liquid biopsy using ctDNA for non-invasive diagnosis
Target Population
Children and young adults aged 3 to 30 years
Care Setting
Tanzania, specifically in limited-resource healthcare settings
Key Highlights
Burkitt Lymphoma is a prevalent childhood malignancy in sub-Saharan Africa.
Current diagnosis relies on invasive biopsy with significant delays.
Liquid biopsy offers a non-invasive alternative with potential for quicker diagnosis.
The cure rate for Burkitt Lymphoma is over 90% in high-income countries but less than 50% in Tanzania.
Economic evaluation highlights the cost-effectiveness of liquid biopsy in resource-limited settings.
Guideline-Based Recommendations
Diagnosis
Consider liquid biopsy as a first-line diagnostic tool for Burkitt Lymphoma in pediatric populations.
Management
Implement chemotherapy protocols based on local guidelines following diagnosis.
Monitoring & Follow-up
Utilize liquid biopsy for real-time disease monitoring and assessment of treatment response.
Risks
Be aware of potential delays in treatment initiation due to diagnostic challenges.
Patient & Prescribing Data
Pediatric and young adult patients with suspected lymphoma.
Liquid biopsy can facilitate timely diagnosis and improve treatment outcomes.
Clinical Best Practices
Integrate liquid biopsy into standard diagnostic workflows for lymphoma.
Ensure access to supportive care to enhance treatment efficacy.
Address systemic barriers to timely diagnosis and treatment in resource-limited settings.
by Jingjing Jiang, Liz Morrell, Malale Tungu, William F. Mawalla, Clara Chamba, Lulu Chirande, Heronima J. Kashaigili, Elifuraha Mkwizu, Paul S. Ntemi, Godlove Sandi, Kristin Schroeder, Anna Schuh, George M. Ruhago, Sarah Wordsworth
